Senior Manager Japan Evidence & Access Strategy – Ion

Primary Function of Position

This role leads the clinical, economic, and access-focused evidence strategy for the Ion Business Unit across Japan markets based in Japan. You own the regional strategy that shows how Ion improves patient outcomes, care pathways, and health-system efficiency – and you use that evidence to unlock and scale access, reimbursement, and adoption.

This role will work closely with APAC Commercial, Country GMs, Clinical Affairs, Product Management, Clinical Development Engineering, Medical Office, and Clinical Marketing, and collaborate with the Global Access Value and Economics (GAVE) team.

Key Responsibilities

• Set the Japan evidence & access strategy
  Define a 3–5 year clinical and economic evidence roadmap for Ion in APAC, linked to clear access, reimbursement, and adoption milestones in priority markets.
• Design and deliver high-impact evidence
  Lead design and prioritization of clinical and economic studies (clinical outcomes, RWE, cost-effectiveness, budget impact, pathway/resource use) that answer payer, HTA, hospital, and clinical decision-maker questions.
• Translate data into value stories
  Turn evidence into locally relevant value propositions, dossiers, slide decks, tools, and decision aids for payers, HTA bodies, hospital value committees, and clinical champions.
• Develop access pathways
  Develop APAC access plans (eg. HTA routes, innovation funding, direct payer contracting, hospital funding logic, coding/reimbursement context), and supply the Ion-specific evidence and analytics needed for submissions and negotiations, without owning pricing or commercial terms.
• Act as the regional Ion “go-to” for evidence & access
  Work with cross-functional teams as the regional Ion expert, and liaison to global headquarters.
• Shape the external environment
  Build and maintain senior relationships with KOLs, professional societies, payers, HTA agencies, and hospital decision-makers; selectively engage in consultations, guidelines, registries, and collaborative studies that move adoption barriers.
• Lead teams, vendors, and budgets
  Provide leadership to direct reports and matrixed contributors. Select and manage HEOR/HTA/MA agencies, CROs, and data vendors. Own or co-own budgets and focus spend on initiatives with measurable access and adoption impact.
• Track impact and course-correct
  Define and monitor KPIs (e.g., HTA decisions, time to funding, procedure volume, contribution of evidence programs). Use policy, competitive, and clinical-trend insights to refine the APAC strategy over time.